ONECLINICAL INTEGRATED CLINICAL ENTERPRISE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ONECLINICAL INTEGRATED CLINICAL ENTERPRISE Trademark

Serial Number: 87595180 • Registration: 5718913

ONECLINICAL INTEGRATED CLINICAL ENTERPRISE is a trademark filed by NAVITAS LIFE SCIENCES HOLDINGS LIMITED on September 4, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NAVITAS LIFE SCIENCES HOLDINGS LIMITED (12 trademarks)

PARKLANDS BUSINESS PARK
DENMEAD, HAMPSHIRE PO6 4XP , GB

Entity Type: 03

Trademark Details

Filing Date

September 4, 2017

Registration Date

April 9, 2019

Published for Opposition

January 22, 2019

Goods & Services

[ Computer software for use in administering clinical drug and medical device trials and submitting documents as part of clinical drug trial approval processes; Computer software for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; computer software platforms for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management ]

scientific and technological services and research and design relating thereto, namely, scientific research, pharmaceutical drug development services, technology research in the field of pharmaceuticals, providing temporary use of on line non-downloadable computer software for submitting documents as part of for clinical drug trial approval processes and for use in pharma and medical device product information management and to address regulatory requirements for pharma and medical device product information management; advisory and consultancy services in the field of biotechnology; advisory services relating to science, namely, consulting services in the field of pharmacovigilance, biopharmaceutical and biotechnology research and consulting services relating to pharma and medical device product information management for pharma and medical device product information management; industrial analysis and research services, namely, industrial research in the field of medical devices; advisory and consultancy services relating to computer networking applications software

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 17, 2026 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 17, 2026 C15P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 17, 2026 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Aug 14, 2025 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 14, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 9, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 9, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 9, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 17, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 28, 2018 GNFN
FINAL REFUSAL E-MAILED
Jun 28, 2018 GNFR
FINAL REFUSAL WRITTEN
Jun 28, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2018 CRFA
ASSIGNED TO LIE
Jun 14, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2017 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Oct 31, 2017 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 31, 2017 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2017 NWOS
NEW APPLICATION ENTERED
Sep 7, 2017 NWAP